Retrofacial Approach for Cochlear Implantation in Chronic Otitis Media: A Case Report.


Journal

The journal of international advanced otology
ISSN: 2148-3817
Titre abrégé: J Int Adv Otol
Pays: Turkey
ID NLM: 101522982

Informations de publication

Date de publication:
Sep 2022
Historique:
pubmed: 17 8 2022
medline: 8 9 2022
entrez: 16 8 2022
Statut: ppublish

Résumé

Cochlear implantation is anatomically more difficult in postoperative ears than in normal ears due to chronic otitis media. In cochlear implantation after canal wall down mastoidectomy, the electrodes must be protected. We report a case of cochlear implantation with partial mastoid obliteration using a retrofacial approach in an 81-year-old woman. Bilateral tympanoplasty was performed for bilateral chronic otitis media, but no improvement in hearing was observed. Hearing aids were used, but their effect was insufficient and cochlear implantation was needed. Since the patient was an older adult with diabetes, it was necessary to avoid the risk of wound infection associated with fat harvesting from the abdomen, which is necessary for overclosure of the external ear. Therefore, we chose to perform partial mastoid obliteration using a retrofacial approach to ensure the prevention of electrode exposure. One year after surgery, the electrode had not been exposed or infected. The ear canal was preserved, and the eardrum could be observed. Although long-term follow-up is required, this approach may be useful for cochlear implantation in patients with chronic otitis media after canal wall down mastoidectomy.

Identifiants

pubmed: 35971268
doi: 10.5152/iao.2022.21357
pmc: PMC9533071
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-454

Références

Otol Neurotol. 2015 Apr;36(4):604-9
pubmed: 25569370
Am J Otol. 1995 Nov;16(6):741-50
pubmed: 8572136
J Laryngol Otol. 2005 Dec;119(12):946-9
pubmed: 16354355
Otol Neurotol. 2003 May;24(3):404-8
pubmed: 12806292
Otol Neurotol. 2015 Mar;36(3):e79-83
pubmed: 25594386
Ear Nose Throat J. 1996 Feb;75(2):77, 81-3, 86-8
pubmed: 8714419
Auris Nasus Larynx. 2019 Aug;46(4):487-492
pubmed: 30442436
Otolaryngol Head Neck Surg. 2016 Oct;155(4):555-63
pubmed: 27221577

Auteurs

Shogo Furuki (S)

Department of Otorhinolaryngology-Head and Neck Surgery, Kitasato University Faculty of Medicine, Kanagawa, Japan.

Hajime Sano (H)

Department of Rehabilitation, Kitasato University Faculty of Allied Health Sciences, Kanagawa, Japan.

Taku Yamashita (T)

Department of Otorhinolaryngology-Head and Neck Surgery, Kitasato University Faculty of Medicine, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH